Loading please wait...
Loading please wait...
Infection Prevention and Control Post COVID-19 PHE
The federal Public Health Emergency (PHE) for COVID-19 ends on May 11, 2023, which will prompt planned updates to data reporting and surveillance of SARS-CoV-2. As a result, the Centers for Disease Control and Prevention (CDC) has updated infection prevention and control recommendations for health care facilities, which were informed by these data. In this town hall, hosted by CDC’s Project Firstline, CDC officials will review the updates to these recommendations and the infection control actions that continue to be effective at stopping the spread of respiratory viruses in health care. This town hall will also feature a panel of health care professionals that will discuss how they will operationalize these updated recommendations in their diverse facilities. CDC’s Project Firstline is proud to partner with the following organizations to reach all health care workers in the U.S. infection control information and education: American Academy of Pediatrics; American Health Care Association; American Medical Association; American Nurses Association; American Society of Nephrology; Armstrong Institute Center for Health Care Human Factors, John Hopkins Medicine; APIC Consulting, LLC; Asian and Pacific Islander American Health Forum; Emory University; Health Research & Educational Trust/American Hospital Association; Johns Hopkins Applied Physics Laboratory; Massachusetts General Hospital; National Association of County and City Health Officials; National Council of Urban Indian Health; National Hispanic Medical Association; National Indian Health Board; National Network of Public Health Institutes; NYC Health + Hospitals; PRISMA Health – Midlands; RTI International; University of Nebraska Medical Center / Nebraska Medicine; University of South Florida; University of Washington; Yale New Haven Health Services Corporation; and 64 state, local, and territorial health departments supported by CDC’s Epidemiology and Laboratory Capacity cooperative agreement.
Alex Kallen, MD, MPH
Alex Kallen is Chief of the Prevention and Response Branch in CDC’s Division of Healthcare Quality Promotion. His Branch is responsible for responding to healthcare outbreaks and developing and implementing guidance to prevent healthcare-associated infections and slow the spread of antibiotic resistant organisms. He has been at CDC for 17 years.
... Show MoreJanet Glowicz MPH, Ph.D. RN, CIC, LTC-CIP
Dr. Janet Glowicz is an Infection Preventionist at the CDC Division of Healthcare Quality Promotion. Dr. Glowicz has practiced infection prevention in a variety of healthcare settings. At the CDC Janet serves as the Hand Hygiene in Healthcare Settings subject matter expert. She has frequently participated in onsite assessments of healthcare facilities in collaboration with the Outbreak Response Team. Janet is a Fellow of APIC and the immediate past president of the Certification Board of Infection Control and Epidemiology.
... Show MoreLinda Behan, BSN, RN, CIC
Linda Behan, BSN, RN, CIC is currently a consultant and President of Long Term Care Infection Prevention, LLC. She served as the Corporate Vice President of Infection Prevention and Control for Genesis HealthCare and has been certified in infection prevention and control since 2011. Linda has presented at APIC Annual Conferences on Antibiotic Stewardship, a Novel Technology to Reduce UTIs and Incontinence-Associated Dermatitis, Enhanced Barrier Precautions to Control Multidrug Resistant Organisms and Infection Surveillance. She is a presenter on infection prevention and control topics for healthcare and other professional associations. Linda was member of the Technical Expert Panel entitled “The Comprehensive Unit-Based Safety Program (CUSP) for Antibiotic Stewardship.” Linda is a member of the faculty for AHCA’s Infection Preventionist Specialized Training (IPCO), contributing modules on Antibiotic Stewardship in Nursing Homes and Water Management Plans. She served on the APIC Professional Development Committee and the APIC LTC Task Force. Linda was a subject matter expert for the development of the APIC LTC-CIP certification preparation course.
... Show MoreLynn Ramirez MD, MSc
Lynn Ramirez MD, MSc, is a Professor of Pediatrics in the Division of Infectious Diseases and Global Health at UC San Francisco and the healthcare epidemiologist at the Benioff Children's Hospital-San Francisco.
... Show MoreErica S. Shenoy, MD, PhD, FIDSA, FSHEA
Dr. Shenoy is Medical Director for Infection Control for Mass General Brigham healthcare system, a large integrated healthcare system with approximately 80,000 employees. In this role, she is responsible for the development and implementation of infection control strategies, policies, and measurement across the Mass General Brigham system. She is an Associate Professor of Medicine at Harvard Medical School and an Infectious Diseases physician at Massachusetts General Hospital (MGH), where she is Associate Chief of the Infection Control Unit. Dr. Shenoy’s research has evaluated the clinical, operational and economic impact of infection control strategies for multi-drug resistant pathogens and prevention of healthcare-associated infections through clinical studies and mathematical modeling, use of electronic health records for surveillance, and applied machine-learning techniques to create risk prediction models for infectious diseases. She is known for her teaching and publications on detection and prevention of nosocomial infections and interventions, evaluation and management of healthcare personnel (HCP) exposure to infectious agents, as well as pre- and post-exposure prophylaxis of HCP. She is the Principal Investigator on a CDC-funded National Infection Prevention and Control and Improving Patient Safety in the United States cooperative agreement focused on HCP and patient safety Dr. Shenoy serves as Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of thirteen federally-funded centers with expertise in preparedness and response for emerging pathogens. In this role, she has responsibility for development and implementation of a comprehensive infection prevention program for the MGH Biocontainment Unit and Special Pathogens Program. Dr. Shenoy is a fellow of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (SHEA). She is currently Chair of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee.
... Show MoreThomas R. Talbot, MD, MPH
Thomas R. Talbot, MD MPH is a Professor of Medicine at Vanderbilt University School of Medicine and also serves as the Chief Hospital Epidemiologist for Vanderbilt University Medical Center (VUMC) in Nashville, TN. Dr. Talbot is a recognized expert in the field of healthcare epidemiology and infection prevention. He has served as a member of the Centers for Disease Control and Prevention’s Healthcare Infection Control Practices Advisory Committee (HICPAC) and currently serves as the President-Elect for the Society for Healthcare Epidemiology of America (SHEA). Dr. Talbot has more than 100 publications in peer-reviewed journals, with original research studies focusing on occupational infection prevention, healthcare personnel vaccination, and improving hand hygiene as a tool to drive a culture of safety.
... Show MoreErica Kaufman West, MD
Erica Kaufman West, MD, completed her undergraduate degrees at Valparaiso University in Indiana. She received her medical degree from Georgetown University School of Medicine. She finished her Internal Medicine residency and her chief resident year at Cedars-Sinai Medical Center in Los Angeles, California. She stayed to complete her fellowship in Infectious Diseases at the West LA VA/Cedars-Sinai/Olive View-UCLA Medical Center program. She has been working in the Midwest since then, focusing on acute inpatient as well as HIV/HCV outpatient care.
... Show More